Is ILMN a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

1,775 people get ILMN articles and Market Currents by email alert.

Get email alerts on ILMN »

HEADLINES:

Illumina Launches BaseSpace® Apps

Business Wire (Thu, 6:30AM)
Illumina Announces Partnerships to Automate TruSeq® and Nextera® Sample Preparation Kits

Business Wire (Wed, 6:30AM)
Illumina to Webcast Live Presentation at Upcoming Investment Conferences in May

Business Wire (May 1, 2013)
Verinata Health Publishes Clinical Laboratory Performance Data for verifi® Prenatal Test

Business Wire (Apr 25, 2013)
Illumina's Solid Quarter Highlights Macroeconomic Resilience, Market Opportunity
PropThink • Thu, Apr 25
Illumina Flexes Its Muscles A Bit
Stephen Simpson • Tue, Apr 23
Illumina Management Discusses Q1 2013 Results - Earnings Call Transcript
Mon, Apr 22
Illumina Names Charles Dadswell as Senior Vice President and General Counsel

Business Wire (Apr 22, 2013)
Illumina Reports Strong Start to Fiscal Year 2013

Business Wire (Apr 22, 2013)
1 Biotech, 1 Financial And An Industrial Goods Company With Recent Intensive Insider Selling
Markus Aarnio • Mon, Apr 22 • 6 Comments
China Biotech In Review: Thermo Fisher Emerges Victorious In Battle To Acquire Life Technologies
ChinaBio Today • Sun, Apr 21
Bulls Sweet On PepsiCo Calls As Shares Rise
Interactive Brokers • Thu, Apr 18
Illumina and Kindstar Global Announce Strategic Collaboration to Facilitate Clinical Adoption of Illumina Technologies in Asia

Business Wire (Apr 18, 2013)
Illumina: Thermo Fisher-Life Deal Unlikely To Threaten Its Market-Leading Position
Helix Investment Research • Wed, Apr 17 • 3 Comments
Thermo Fisher Buys Life Technologies At A Knock-Out Price
The Value Investor • Tue, Apr 16
Sequencing Is Hot: Life Technologies Deal Has Implications For Illumina
PropThink • Mon, Apr 15
Illumina to Announce First Quarter 2013 Financial Results on Monday, April 22, 2013

Business Wire (Apr 8, 2013)
ResMed: CMS Takes Rungs Out Of Ladder
Nassarius Capital • Fri, Apr 5 • 8 Comments
Illumina Launches TruSight™ Tumor Content Set

Business Wire (Apr 4, 2013)
Illumina Technology Enables Findings of the Collaborative Oncological Gene-Environment Study (COGS)

Business Wire (Mar 27, 2013)

Illumina: Thermo Fisher-Life Deal Unlikely To Threaten Its Market-Leading Position
Helix Investment Research • Wed, Apr 17 • 3 Comments

Illumina's Solid Quarter Highlights Macroeconomic Resilience, Market Opportunity
PropThink • Thu, Apr 25
Illumina Flexes Its Muscles A Bit
Stephen Simpson • Tue, Apr 23
Illumina: Thermo Fisher-Life Deal Unlikely To Threaten Its Market-Leading Position
Helix Investment Research • Wed, Apr 17 • 3 Comments
Sequencing Is Hot: Life Technologies Deal Has Implications For Illumina
PropThink • Mon, Apr 15
Genomics Conference Illustrates That Illumina Is Outpacing The Competition
PropThink • Fri, Mar 15 • 1 Comment
Illumina: Side Stepping Macro Pressure And Delivering In The Long Term
PropThink • Wed, Feb 6 • 1 Comment
Roche Is Back; Buyout Leak Is Unsurprising
PropThink • Thu, Dec 20, 2012
Embryo Genetic Testing Like Illumina And BlueGnome's Version Doubles Rate Of 'Singleton' Babies From In Vitro Fertilization
Rex Graham • Tue, Oct 23, 2012 • 1 Comment
Is Illumina In Play? Analyzing The CEO's Comments, Financials, And The State Of Business
Helix Investment Research • Mon, Sep 24, 2012 • 4 Comments
Illumina Tries To Get The Kool-Aid Flowing Again
Stephen Simpson • Tue, Apr 24, 2012 • 4 Comments
Illumina Stays Independent But Drops As Roche's Offer Expires
The Burrill Report • Sun, Apr 22, 2012
Analyzing The Roche Offer To Illumina
Dave Westenberg • Mon, Feb 27, 2012 • 12 Comments
Illumina, Roche And Fairness
Prohost Biotech • Thu, Feb 9, 2012 • 3 Comments
Illumina Reports Earnings Tuesday: Stock Is Booming Despite Massive Short Interest
Robert Weinstein • Fri, Jan 27, 2012
Illumina - 3 Times Is Lucky?
The Value Investor • Thu, Jan 26, 2012
Illumina Has Very Small Upside At These Levels
Ivan Mutaftchiev • Thu, Jan 26, 2012
Illumina Should Still Fall, But May Be A Buying Opportunity Into Peers
GuruFundPicks • Mon, Oct 10, 2011 • 2 Comments
Is The Pain Over For Illumina?
VFC's Stock House • Sun, Oct 9, 2011 • 1 Comment
Illumina's Business Hangs On Government Funding Of Its Clients
Ted Stamas • Thu, Oct 6, 2011 • 2 Comments
Profits Are in Illumina's DNA
Todd Campbell • Mon, Jun 13, 2011 • 2 Comments

1 Biotech, 1 Financial And An Industrial Goods Company With Recent Intensive Insider Selling
Markus Aarnio • Mon, Apr 22 • 6 Comments
China Biotech In Review: Thermo Fisher Emerges Victorious In Battle To Acquire Life Technologies
ChinaBio Today • Sun, Apr 21
Bulls Sweet On PepsiCo Calls As Shares Rise
Interactive Brokers • Thu, Apr 18
Thermo Fisher Buys Life Technologies At A Knock-Out Price
The Value Investor • Tue, Apr 16
ResMed: CMS Takes Rungs Out Of Ladder
Nassarius Capital • Fri, Apr 5 • 8 Comments
Positive Catalysts For Illumina, Stryker: How To Invest
Nick Chiu • Mon, Mar 4
M&A Chatter Shouldn't Obscure Better Results At Life Tech
Stephen Simpson • Wed, Feb 6
Here Are Some More Stocks That Could Crush Shorts
Alan Brochstein • Wed, Jan 30 • 31 Comments
The Week Ahead: Earnings From Caterpillar, Yahoo And Facebook Plus Key Economic Data
James Hartje • Mon, Jan 28 • 2 Comments
Is Pacific Biosciences A Possible Takeover Target?
Kevin Quon • Fri, Jan 11 • 4 Comments
First Half Of 2013 To Be A Critical Time For Exact Sciences
Josh Hutheson • Wed, Jan 9 • 1 Comment
Cramer's Mad Money - Which Sectors Will Make A Comeback In 2013? (1/7/13)
SA Editor Miriam Metzinger • Tue, Jan 8 • 1 Comment
Wall Street Breakfast: Must-Know News
Wall Street Breakfast • Mon, Jan 7 • 100 Comments
Options Scan On Thursday: Unusual Call Activities For Nationstar Mortgage And Illumina
Nick Chiu • Fri, Dec 21, 2012
Thursday Options Brief: HLF, ILMN & WSM
Interactive Brokers • Thu, Dec 20, 2012
Wall Street Breakfast: Must-Know News
Wall Street Breakfast • Thu, Dec 20, 2012 • 140 Comments
Can Amgen Unlock DeCODE's Value?
Stephen Simpson • Mon, Dec 10, 2012 • 1 Comment
The Road Toward Far-Reaching Therapeutics Through Illumina, Sarepta
Prohost Biotech • Tue, Dec 4, 2012 • 3 Comments
Hedge Funds Are Buying These 6 High-Growth Biotech Stocks
Kapitall • Thu, Nov 22, 2012 • 6 Comments
Roche Seeking Gene Sequencing Partner
Stock Traders Daily • Mon, Nov 5, 2012 • 4 Comments

Illumina Management Discusses Q1 2013 Results - Earnings Call Transcript
Mon, Apr 22
Illumina Management Discusses Q4 2012 Results - Earnings Call Transcript
Mon, Jan 28
Illumina Management Discusses Q3 2012 Results - Earnings Call Transcript
Tue, Oct 23, 2012
Illumina Management Discusses Q2 2012 Results - Earnings Call Transcript
Wed, Jul 25, 2012
Illumina's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Mon, Apr 23, 2012 • 1 Comment
Illumina's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Wed, Feb 8, 2012
Illumina's CEO Hosts Illumina Transaction Conference Call (Transcript)
Wed, Jan 25, 2012
Illumina's CEO Discusses Q3 2011 Results - Earnings Call Transcript
Tue, Oct 25, 2011
Illumina's CEO Discusses Q2 2011 Results - Earnings Call Transcript
Wed, Jul 27, 2011
Illumina's CEO Discusses Q1 2011 Results - Earnings Call Transcript
Wed, Apr 27, 2011
Illumina's CEO Discusses Q4 2010 Results - Earnings Call Transcript
Wed, Feb 9, 2011 • 1 Comment
Illumina CEO Discusses Q3 2010 Results - Earnings Call Transcript
Tue, Oct 26, 2010
Illumina Q1 2010 Earnings Call Transcript
Thu, Apr 29, 2010
Illumina, Inc Q4 2009 Earnings Call Transcript
Thu, Feb 4, 2010
Illumina Q3 2009 Earnings Call Transcript
Wed, Oct 28, 2009
Illumina, Inc. Q2 2009 Earnings Call Transcript
Wed, Jul 22, 2009
Illumina, Inc. Q1 2009 Earnings Call Transcript
Wed, Apr 22, 2009
Illumina Inc. Q4 2008 Earnings Call Transcript
Tue, Feb 3, 2009
Illumina Inc. Q3 2008 Earnings Call Transcript
Tue, Oct 21, 2008
Illumina Inc. Q2 2008 Earnings Call Transcript
Tue, Jul 22, 2008

Illumina Launches BaseSpace® Apps

Business Wire (Thu, 6:30AM)
Illumina Announces Partnerships to Automate TruSeq® and Nextera® Sample Preparation Kits

Business Wire (Wed, 6:30AM)
Illumina to Webcast Live Presentation at Upcoming Investment Conferences in May

Business Wire (May 1, 2013)
Verinata Health Publishes Clinical Laboratory Performance Data for verifi® Prenatal Test

Business Wire (Apr 25, 2013)
After-Hours Buzz: NFLX, TXN, ZION & More

at CNBC.com (Apr 22, 2013)
Illumina Names Charles Dadswell as Senior Vice President and General Counsel

Business Wire (Apr 22, 2013)
Illumina Reports Strong Start to Fiscal Year 2013

Business Wire (Apr 22, 2013)
Illumina and Kindstar Global Announce Strategic Collaboration to Facilitate Clinical Adoption of Illumina Technologies in Asia

Business Wire (Apr 18, 2013)
Ben Weiss's Eye on Asia: Genomics companies ripe for flurry of mergers

at MarketWatch.com (Apr 16, 2013)
Illumina to Announce First Quarter 2013 Financial Results on Monday, April 22, 2013

Business Wire (Apr 8, 2013)
Illumina Launches TruSight™ Tumor Content Set

Business Wire (Apr 4, 2013)
Illumina Technology Enables Findings of the Collaborative Oncological Gene-Environment Study (COGS)

Business Wire (Mar 27, 2013)
Illumina Announces Favorable Outcome of Its Patent Litigation Against Life Technologies, Inc.

Business Wire (Mar 21, 2013)
Illumina Announces Outcome of Its Patent Litigation Against Syntrix Biosystems, Inc.

Business Wire (Mar 14, 2013)
Illumina Completes Acquisition of Verinata Health

Business Wire (Feb 21, 2013)
Illumina to Webcast Live Presentation at the Cowen and Company Annual Health Care Conference

Business Wire (Feb 20, 2013)
After-Hours Buzz: YHOO, VMW & More

at CNBC.com (Jan 28, 2013)
Illumina Reports Record Financial Results for Fourth Quarter and Fiscal Year 2012

Business Wire (Jan 28, 2013)
Illumina Announces Recipients of Agricultural Greater Good Initiative Grants

Business Wire (Jan 15, 2013)
Illumina to Announce Fourth Quarter and Fiscal Year 2012 Financial Results on Monday, January 28, 2013

Business Wire (Jan 15, 2013)

ILMN vs. ETF Alternatives

Company Description

We are a leading developer, manufacturer, and marketer of integrated systems for the analysis of genetic variation and biological function. We were incorporated in California in April 1998 and reincorporated in Delaware in July 2000. Our principal executive offices are located at 9885 Towne... More

Sector: Healthcare

Industry: Biotechnology

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Wednesday, May 15, 6:03 PM Third Point discloses new positions in: Anadarko Petroleum (APC), BE Aerospace (BEAV), Cabot Oil (COG), Chimera Investment (CIM), Hess (HES), Hilshire Brands (HSH), Tiffany (TIF), Thermo Fisher (TMO), and Virgin Media (MMED). It raises stakes in: AbbVie (ABBV) and International Paper (IP), and exits Abbott Labs (ABT), Capital One (COF), Coca-Cola Enterprises (CCE), Herbalife (HLF), Illumina (ILMN), MetLife (MET), Morgan Stanley (MS) and Tesoro (TSO). (13-F) 4 Comments
Friday, May 10, 3:29 PM Shares of Illumina (ILMN +10%) ramp higher today, spiking up on heavy volume with no apparent news driving the move. Of note; short interest in the stock continues to inch higher, but days to cover has plummeted as average daily volume in the shares has nearly doubled since March, bringing it back to nearly 2M shares per day, a level it hasn't seen since January - and perhaps an indication of piquing institutional interest. Comment! [Healthcare, On the Move]
Tuesday, April 23, 12:56 PM Midday top 10 gainers: SCON +118%. MEMS +49%. CZR +29%. NFLX +24%. ARL +18%. CPLA +18%. VECO +17%. HSTM +17%. SANM +16%. ILMN +15%.
Midday top 10 losers: CPRX -15%. IIVI -13%. UNTK -13%. ABIO -13%. CASM -10%. EFUT -9%. GASS -9%. TAX -8%. SIFY -7%. USTR -7%. Comment! [On the Move]
Tuesday, April 23, 9:27 AM Illumina (ILMN) moves higher in pre-trading after easily beating on its Q1 yesterday. In its conference call, the company reiterates that it expects a 2% - 4% impact as a result of sequestration, suggesting the damage will likely be limited. One of the offsetting factors management mentions is that "under the continuing resolution much of the NIH allocation was at 90% of the grant amount and so that has a potential small upside effect that could neutralize any of the downside effects from sequestration." Read more on the call here: (Earnings Call Transcript). Shares +9.3% pre-open. Comment! [Healthcare, Earnings, On the Move]
Tuesday, April 23, 9:10 AM Premarket gainers: MEMS +50%. SCON +46%. NFLX +24%. VECO +14%. COH +12%. ILMN +10%. ARMH +9%. CZR +8%. STM +6%. AMRN +6%.
Losers: IRWD -10%. RSH -7%. IOC -6%. Comment! [On the Move]
Monday, April 22, 5:54 PM After-hours top gainers, as of 5:15 p.m.: VECO +9%. SWFT +6%. ILMN +4%. WIT +4%. QCCO +3%.
After-hours top losers: BEAT -11%. RCII -6%. HOV -5%. RFMD -5%. REGI -4%. 1 Comment [On the Move]
Monday, April 22, 5:10 PM More on Illumina (ILMN): The stock is trading higher in the post session as its Q1 easily beats across the board on a 21% jump in revenue Y/Y. The company swung to a net loss for the quarter however, after taking nearly a $107M loss related to its unfavorable verdict in its patent litigation with Syntrix Biosystems. R&D and SG&A expenses were both higher as a percentage of revenue, while margins were relatively flat compared to the prior year. Shares +4.3% AH. Comment! [Earnings, On the Move]
Monday, April 22, 4:20 PM Illumina (ILMN): Q1 EPS of $0.46 beats by $0.07. Revenue of $331M beats by $20.36M. Shares +4.3% AH. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
Monday, April 22, 12:10 AM Notable earnings after Monday’s close: ACE, AMP, CNI, HXL, ILMN, NFLX, NXPI, PKG, RCI, SANM, STM, SWFT, TXN, VECO, ZION Comment! [Earnings]
Sunday, April 21, 5:35 PM Notable earnings after Monday’s close: ACE, AMP, CNI, HXL, ILMN, NFLX, NXPI, PKG, RCI, SANM, STM, SWFT, TXN, VECO, ZION Comment! [Earnings]
Thursday, April 18, 7:52 AM Illumina (ILMN) says its TruSight content sets and Infinium assays will be adopted by Kindstar Global across a network of 3,300 hospitals in China. Separately, SA contributor PropThink says Thermo Fisher's "willingness to pay up for Life Technologies" may reignite talks between ILMN and longtime suitor Roche, as the deal shows "premiums in this expanding segment of healthcare aren't unheard of." Comment! [Healthcare]
Thursday, March 28, 4:33 PM Halozyme Therapeutics (HALO) says it's appointed Matt Posard to its Board of Directors. Mr. Posard is currently SVP and General Manager of Translational & Consumer Genomics at Illumina (ILMN). Shares +0.2% AH Comment! [Healthcare]
Thursday, March 21, 4:33 PM Illumina (ILMN) wins a favorable judgment in its patent litigation against Life Technologies (LIFE), with the court saying that its sequencing systems do not infringe on LIFE's patents. Life Technologies filed the lawsuit against ILMN in 2009. The Court ruled that, “Life Tech cannot establish, as a matter of law, that the accused Illumina systems infringe” the patents. ILMN +1.4% AH. Comment! [Healthcare, On the Move]
Monday, January 28, 4:31 PM More on Illumina (ILMN): Q4 beats on the top line as total sales jump 24% Y/Y. The company also guides FY13 earnings lower, now expecting to see its EPS in the range of $1.55 - $1.62, below ccurrent Street estimates of $1.73. Comment! [Healthcare, Earnings]
Monday, January 28, 4:10 PM Illumina (ILMN): Q4 EPS of $0.42 in-line. Revenue of $309M (+24% Y/Y) beats by $4M. (PR) Shares -0.4% AH. Comment! [Healthcare, Earnings, Breaking News]
Monday, January 28, 12:10 AM Notable earnings after Monday’s close: BMC, CE, IDTI, ILMN, MSPD, OLN, SANM, STLD, STX, VMW, YHOO, ZION Comment! [Earnings]

Holly Thompson
Premarket gainers: $MEMS +50% $SCON +46% $NFLX +24% $VECO +14% $COH +12% $ILMN +10% $ARMH +9% $CZR +8% $STM +6% $AMRN +6%
Apr 23, 9:16 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ltfinger
New Upgrades (3/26/13): $BSFT, $CEO, $CL, $EWW, $FTI, $GLNG, $ILMN, $LOGM, $OII, $RS, $SBS, $SCTY, $UNH
Mar 27, 3:37 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ltfinger
Today's New Downgrades (3/19/13): $CAH, $CAM, $CERN, $CNI, $CRM, $CSC, $DSW, $EXPE, $FDS, $FTI, $FTNT, $GNC, $HOG, $HP, $ILMN, $JAH
Mar 20, 8:46 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ltfinger
Today's Potential Downgrades (3/18/13): , $ILMN, $IOC, $LNKD, $MDCO, $MGA, $MLNX, $MON, $NOW, $OCN, $OII, $PCLN, $PCYC, $PG, $PII, $PLCE
Mar 19, 7:43 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Alan Brochstein
$ILMN has had a nice recovery and looks attractive on the chart and even valuation relative to its history
Mar 2, 3:18 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Ryan Mallory
$ILMN Swing Trade Quick Pick: Illumina Inc (ILMN) | http://bit.ly/12SO5qY
Feb 21, 2:45 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Alan Brochstein
$ILMN is heavily shorted, reported and barely moved on "bad" news - probably headed higher
Jan 29, 6:42 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Ryan Mallory
Mid-Day Charts & Technical Analysis: $FB $APKT $ILMN & Others | SharePlanner http://bit.ly/TWnalJ
12/17/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Clark
SHORT: EL, BP, EWC (Canada), EWG (Germany), EWS (Singapore), EW (France), RDS-A, LULU, FDX, CRM, NOC, C, SAN, JPM LONG: SKF, EUO, ILMN, IMAX
11/12/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Ryan Mallory
WSN's Top Watchers for the Week of 10/28 by @wallstreetnole $RVBD $ILMN $WLT $CTRP $MNST http://bit.ly/XI17mO
10/28/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

Tony Kau
$ILMN looking exhausted, time to start acquiring? http://bit.ly/HQJs6D
4/17/12
Reply (1)

• !Report Abuse
View all 1 replies
jowl: Started a position today regardless of how the meeting turns out tomorrow. Roche has always been willing to pay up, let's hope it continues
4/17/12
• !Report Abuse
Add a reply...

140 characters

Holly Thompson
Illumina (ILMN) upgraded to Outperform from Neutral at RW Baird. Rises 38.8%.
1/25/12
Reply (2)

• !Report Abuse
View all 2 replies
New Low Observer: classic move...didn't notice it before, but after the offer is made..."oh yeah, upgrade"...thanks RW Baird for the 20/20 hindsight...
1/26/12
• !Report Abuse
Holly Thompson: Doesn't it seem as if this happens most of the time...Makes me laugh when the piece comes out but almost always helps our stock.
3/21/12
• !Report Abuse
Add a reply...

140 characters

freefdawatchlist
Stocks for Feb 6th: VXX, TZA,FAZ, ERY, YUM, ILMN http://bit.ly/xj5vHG
2/6/12
Reply (1)

• !Report Abuse
View all 1 replies
Maria Auziliadora: I like ILMN but i think CRL is another takeover target
2/9/12
• !Report Abuse
Add a reply...

140 characters

talbano
roche offerring 5.7 b for ILMN
1/24/12
Reply (1)

• !Report Abuse
View all 1 replies
talbano: about 44-45 share i think
1/24/12
• !Report Abuse
Add a reply...

140 characters

Dr. Kris
#1 reason not to hold a stock over earnings: A company lowers future guidance. Doing just that today: ANEN (-9%) and ILMN (-33%).
10/7/11
Reply (3)

• !Report Abuse
View all 3 replies
Dr. Kris: There's investing for the long haul (which is what you're espousing) and there's trading in the short-term. Each has its own set of rules.
10/7/11
• !Report Abuse
golfitobob: 100% agree.I am short term,but,your the top here & must know that the biggest pros buy AAPL close to release & sell into.So it's Co.Specific
10/7/11
• !Report Abuse
Add a reply...

140 characters

Justin M. Hall
8/6/11 12A ET: (VRUS, ALXN, BIIB, ILMN, PRGO) BIOTECH CORRECTION Called in June 2011 => Were You Paying Attention? http://seekingalpha.com/p/4bsg
8/6/11
Reply (1)

• !Report Abuse
View all 1 replies
John Rayhall: ILMN is down 36% pre-market seems a little overdone no?
10/7/11
• !Report Abuse
Add a reply...

140 characters

ILMN Illumina, Inc.

ILMN

Illumina, Inc.